About
Our research focuses on the health issues of blindness, cancer and drug abuse, which have huge socioeconomic implications.
Our lab applies engineering principles to advance our understanding of the interactions of therapeutic nanoparticle platforms with biological barriers and disease pathophysiology. This knowledge guides us to better design new biomaterials and nanotherapeutic-based treatments for eye disorders, cancer and other diseases.
Our research program operates at the interface of nanoengineering, materials science and translational medicine. We aim to translate technologies to have a meaningful impact on human health.
News
Drs. Xu and Jian-xing Ma at Wake Forest University received an MPI UG3 "Fenofibrate microemulsion for treating nitrogen mustard induced corneal injury" ($1.6 million over 3 years) from NIH/NEI.
Congratulations to Sagun Poudel for successfully passing her Ph.D. defense! Sagun started as an analytical characterization scientist (Eurofins PSS).
Dr. Xu was promoted to full professor of pharmaceutics, effective on July 1.